Universe Pharmaceuticals (UPC) Non-Current Assets (2020 - 2025)

Universe Pharmaceuticals has disclosed Non-Current Assets across 6 years of filings, most recently posting $15.7 billion for Q3 2025.

• Non-Current Assets for Q3 2025 came in at $15.7 billion, down 3.77% year-over-year; the trailing twelve-month figure through Sep 2025 was $15.7 billion (down 3.77% YoY), and the FY2025 annual result was $15.7 billion, down 3.77% from the prior year.
• Non-Current Assets came in at $15.7 billion for Q3 2025 at Universe Pharmaceuticals, down from $16.3 billion in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $16.3 billion in Q3 2024 to a low of $15.9 million in Q1 2024.
• The 5-year median for Non-Current Assets is $18.8 million (2021), against an average of $4.0 billion.
• Across the five-year window, Non-Current Assets sank 100.0% in 2021 and surged 99054.25% in 2024, its largest moves.
• Universe Pharmaceuticals' Non-Current Assets stood at $19.7 million in 2021, then fell by 8.29% to $18.0 million in 2022, then retreated by 8.76% to $16.5 million in 2023, then soared by 99054.25% to $16.3 billion in 2024, then dropped by 3.77% to $15.7 billion in 2025.
• The last three Non-Current Assets figures came in at $15.7 billion (Q3 2025), $16.3 billion (Q3 2024), and $15.9 million (Q1 2024), per Business Quant data.